论文部分内容阅读
目的探讨妈富隆治疗青春期功能失调性子宫出血(功血)的临床疗效。方法本组56例患者,随机分为观察组和对照组各28例。对照组给予经典雌激素疗法;观察组给予妈富隆1片口服,每日三次治疗,出血得到控制后药物剂量逐渐递减。两组患者治疗过程中均注意是否出现不良反应。结果观察组出血控制情况及完全止血时间与对照组相比无显著性差异(P>0.05),且不良反应少,但对照组患者均需住院治疗,而观察组绝大部分患者门诊即可治疗。结论对于青春功血患者,应用妈富隆即可达到很好的治疗效果,且不需住院,不良反应小,值得在临床中推广应用。
Objective To investigate the clinical efficacy of Marvelon in the treatment of adolescent dysfunctional uterine bleeding (DUB). Methods 56 patients in this group were randomly divided into observation group and control group, 28 cases each. The control group was given classical estrogen therapy. The observation group was given oral administration of Marvelon once daily for three times. After the bleeding was controlled, the dosage of the drug gradually decreased. Two groups of patients were treated with attention to whether there are adverse reactions. Results There was no significant difference in bleeding control and complete hemostasis time between the observation group and the control group (P> 0.05), and fewer adverse reactions, but patients in the control group were required to be hospitalized, and the vast majority of patients in the observation group were treated clinically . Conclusion For young patients with dysfunctional uterine bleeding, the application of Marvelon can achieve good therapeutic effect without hospitalization and has small adverse reactions. It is worth to be popularized and applied in clinical practice.